Systematic review of 43 studies (34 meta-analysed) of AI tools in prostate cancer: pooled AUC 0.845 for diagnostic and 0.785 for prognostic tools; deep learning outperformed classical models; applicability concerns remained.
Meta-analysisn = 43 studies
Tun et al. Artificial Intelligence (AI)-based tools in the diagnosis and management of prostate cancer: a systematic review and meta-analysis